Shanghai City, China Clinical Trials

A listing of Shanghai City, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1223 clinical trials
Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer

CREST: Combination of sasanlimab and alternative BCG Regimens to Evaluate outcomes with Subcutaneous anti-PD-1 Treatment Phase 3 Design with 3 study Arms (A, B and C). Arms A and B consists of two study drugs, PF-06801591 plus BCG. Arm C consists of one study drug, BCG. The study is designed …

Fudan University Cancer Hospital
 (2.3 away) Contact site
  • 10 views
  • 01 Aug, 2021
  • +217 other locations
Efficacy Safety and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

Phase 3 study to determine the efficacy, safety, and tolerability of aztreonam- avibactam (ATM- AVI) versus best available therapy (BAT) in the treatment of hospitalized adults with complicated intra-abdominal infections (cIAI), nosocomial pneumonia (NP) including hospital acquired pneumonia (HAP) and ventilator associated pneumonia (VAP), complicated urinary tract infections (cUTI), or …

National Taiwan University Hospital
 (425.9 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +44 other locations
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma 2cm

This study aims to evaluate the non-inferiority in recurrence-free survival and overall survival of segmentectomy compared with lobectomy in patients with lung adenocarcinoma 2 cm with micropapillary and solid subtype negative by intraoperative frozen sections.

Shanghai Pulmonary Hospital
 (5.5 away) Contact site
  • 0 views
  • 03 Jul, 2021
  • +5 other locations
A Study to Evaluate CBP-201 in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps

This study will evaluate the effect of CBP-201 in adult patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Connect Investigative Site 301
 (1.8 away) Contact site
  • 0 views
  • 01 Jul, 2021
  • +28 other locations
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

The purpose of this study is to evaluate the efficacy of helicobacter pylori (HP) eradication with bismuth-containing quadruple therapy with vonoprazan versus esomeprazole in all HP-positive participants.

clarithromycin
bismuth
amoxicillin
omeprazole
helicobacter pylori infection
Shanghai East Hospital
 (0.1 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +28 other locations
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

The purpose of the study is to evaluate on-treatment efficacy against hepatitis D virus (HDV) of JNJ-73763989 + nucleos(t)ide analog (NA) regimen compared to NA alone.

Huashan Hospital Fudan University
 (1.7 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • +70 other locations
A 5-year Study to Test BI 655130 in Patients With Generalized Pustular Psoriasis Who Took Part in Previous Studies With BI 655130

To evaluate the long-term safety and efficacy of BI 655130 in patients with GPP, who have completed previous BI 655130 trials and are qualified for entry in this trial

Huashan Hospital, Fudan University
 (1.7 away) Contact site
  • 0 views
  • 20 Jul, 2021
  • +24 other locations
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis

The purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active nonradiographic axial spondyloarthritis (nr-axSpA).

As0010 20018
 (0.0 away) Contact site
  • 27 views
  • 01 Aug, 2021
  • +189 other locations
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

The aim of this study is to compare the efficacy and safety of YIV-906 plus standard-of-care sorafenib versus those of sorafenib alone as a first-line systemic treatment for patients with Hepatitis B (+) associated advanced hepatocellular carcinoma. YIV-906 (PHY906, KD018) is an immune system modulator. Clinical and preclinical research suggests …

Shanghai University of Traditional Chinese Medicine Shuguang Hospital
 (0.0 away) Contact site
  • 2 views
  • 27 Jan, 2021
  • +31 other locations
A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

This is a randomized, open-label, international, multi-center, phase III trial to evaluate the efficacy and safety of SHR-1210 plus apatinib mesylate versus sorafenib as first-line therapy in patients with advanced HCC.

Shanghai Changhai Hospital
 (0.0 away) Contact site
  • 10 views
  • 23 Jan, 2021
  • +34 other locations